Premium
Remission of paroxysmal atrial fibrillation with iron reduction in haemophilia A
Author(s) -
ZACHARSKI L. R.,
MCKERNAN L.,
METZGER M. E.,
MALONE M. G.,
SAMNOTRA V.,
BHARGAVA A.,
STEINER P. R.,
RAUWERDINK C. A.,
ORNSTEIN D. L.,
CORNELL C. J.
Publication year - 2010
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.2010.02218.x
Subject(s) - medicine , phlebotomy , paroxysmal atrial fibrillation , hemochromatosis , atrial fibrillation , haemophilia , iron deficiency , ferritin , pediatrics , cardiology , surgery , anemia
Summary. Two male first cousins with mild haemophilia A had baseline factor VIII levels of 12–15% and experienced bleeding requiring coagulation factor infusion therapy with trauma and surgical procedures. Both the patients with haemophilia A also had electrocardiographically documented symptomatic paroxysmal atrial fibrillation (PAF) for several years that had become resistant to pharmacological suppression. Radiofrequency ablation was considered in both the cases but deferred considering refusal of consent by the patients to undergo the procedure. Remission of arrhythmias has been reported in patients with iron‐overload syndromes. Body iron stores assessed by serum ferritin levels were elevated in both men but neither had the C282Y or H63D genes for haemochromatosis. Calibrated reduction of iron stores by serial phlebotomy, avoiding iron deficiency, was followed by remission of symptomatic PAF in both cases. Iron reduction may be an effective treatment for arrhythmias apart from the classic iron‐overload syndromes and deserves further study particularly in patients with bleeding disorders who might be at risk for arrhythmias and other diseases of ageing.